You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雲南白藥(000538.SZ)2021年預算主要指標:淨利潤預計同比不低於上年同期、淨資產收益率不低於10.5%
格隆匯 03-26 19:42

格隆匯 3 月 26日丨雲南白藥(000538.SZ)公佈,公司屆董事會2021年第次會議決議,審議通過《2021年度財務預算報吿》;該項議案尚需提交公司2020年度股東大會審議。

2021年,公司將繼續借助混改為公司帶來的全新市場化機制,把握機遇,緊緊圍繞新白藥、大健康戰略,提升資源配置效率,降本、提質、增效,全力升級大健康產業。

2021年預算主要指標:淨利潤預計同比不低於上年同期;淨資產收益率不低於10.5%

特別説明:該預算旨在明確公司經營及內部管理控制目標,並不代表公司2021年盈利預測,更不代表對投資者的承諾。預算數據能否實現取決於宏觀經濟環境、市場情況、行業發展狀況與公司管理團隊的努力等諸多因素,存在較大的不確定性,敬請廣大投資者特別注意。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account